These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 19543052)

  • 61. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
    Duan X; Yang L; Dong S; Xin R; Chen G; Guo L
    Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Coencapsulation of hepatocytes with bone marrow mesenchymal stem cells improves hepatocyte-specific functions.
    Shi XL; Zhang Y; Gu JY; Ding YT
    Transplantation; 2009 Nov; 88(10):1178-85. PubMed ID: 19935371
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recipient blood pre-transplant transfusion prolongs hepatic allograft survival in rats.
    Wang FS; Yamaguchi Y; Furuhashi T; Uchino S; Kihara S; Yamada S; Mori K; Ogawa M
    J Surg Res; 2006 Sep; 135(1):52-60. PubMed ID: 16716354
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
    Villaron EM; Almeida J; López-Holgado N; Alcoceba M; Sánchez-Abarca LI; Sanchez-Guijo FM; Alberca M; Pérez-Simon JA; San Miguel JF; Del Cañizo MC
    Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Generation of donor hematolymphoid cells after rat-limb composite grafting.
    Ajiki T; Takahashi M; Inoue S; Sakuma Y; Oyama S; Kaneko T; Hakamata Y; Murakami T; Kume A; Kariya Y; Hoshino Y; Kobayashi E
    Transplantation; 2003 Mar; 75(5):631-6. PubMed ID: 12640301
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.
    Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S
    Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression.
    Huang H; He J; Teng X; Yu Y; Ye W; Hu Y; Shen Z
    J Surg Res; 2013 Dec; 185(2):896-903. PubMed ID: 23870834
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects.
    Dai W; Hale SL; Martin BJ; Kuang JQ; Dow JS; Wold LE; Kloner RA
    Circulation; 2005 Jul; 112(2):214-23. PubMed ID: 15998673
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats.
    Zhou H; Tian HM; Long Y; Zhang XX; Zhong L; Deng L; Chen XH; Li XQ
    Chin Med J (Engl); 2009 Nov; 122(21):2573-9. PubMed ID: 19951572
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation.
    Pakkala I; Taskinen E; Pakkala S; Räisänen-Sokolowski A
    Bone Marrow Transplant; 2001 Apr; 27(8):863-7. PubMed ID: 11477445
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.
    Freyman T; Polin G; Osman H; Crary J; Lu M; Cheng L; Palasis M; Wilensky RL
    Eur Heart J; 2006 May; 27(9):1114-22. PubMed ID: 16510464
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New strategies for allogeneic BMT.
    Ikehara S
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S73-5. PubMed ID: 12931248
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.
    Song H; Chang W; Lim S; Seo HS; Shim CY; Park S; Yoo KJ; Kim BS; Min BH; Lee H; Jang Y; Chung N; Hwang KC
    Stem Cells; 2007 Jun; 25(6):1431-8. PubMed ID: 17347495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Infusion of nonmyeloablative bone marrow alleviates acute rejection reaction in liver allotransplantation.
    Xie HY; Huang DS; Jia CK; Zheng SS
    J Zhejiang Univ Sci B; 2005 Dec; 6(12):1188-94. PubMed ID: 16358377
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine.
    Hewitt CW; Black KS; Henson LE; Achauer BM; Nguyen JH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):272-8. PubMed ID: 3259042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation].
    Ran HH; Pan KL; Zhang R; Wang YF
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):408-12. PubMed ID: 17052403
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improvement of heart allograft acceptability associated with recruitment of CD4+CD25+ T cells in peripheral blood by recipient treatment with granulocyte colony-stimulating factor.
    Liang HL; Yi DH; Zheng QJ; Du JF; Cao YX; Yu SQ; Zhu HL
    Transplant Proc; 2008 Jun; 40(5):1604-11. PubMed ID: 18589159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.